http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103860545-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103860545-B |
| titleOfInvention | Arctigenin purposes in preparation treatment oneself immunity hepatitis medicine |
| abstract | The present invention is claimed arctigenin medical usage in preparation treatment autoimmune liver disease, belongs to field of medicaments.Arctigenin is to extract the effective traditional Chinese medicine monomer obtained from traditional Chinese medicine great burdock achene, it can significantly improve the ratio between the immune cell factor of patient when autoimmune liver disease is treated, significantly reduce transaminase content and the liver index of patient, such that it is able to play, autoimmune liver disease particularly oneself immunity hepatitis is played the effect treated both principal and secondary aspect of disease.During arctigenin medication, toxic and side effect is little, and determined curative effect is cheap, and medical application prospect is the most wide. |
| priorityDate | 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.